協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2015/09/28 | 1,785 | 1,802 | 1,735 | 1,759 | -13 | -0.7% | 1,338,000 |
| 2015/09/25 | 1,768 | 1,806 | 1,740 | 1,772 | +44 | +2.5% | 1,705,000 |
| 2015/09/24 | 1,778 | 1,787 | 1,728 | 1,728 | -83 | -4.6% | 2,375,000 |
| 2015/09/18 | 1,817 | 1,860 | 1,811 | 1,811 | -36 | -1.9% | 1,708,000 |
| 2015/09/17 | 1,870 | 1,870 | 1,825 | 1,847 | -17 | -0.9% | 1,133,000 |
| 2015/09/16 | 1,885 | 1,888 | 1,843 | 1,864 | -13 | -0.7% | 1,053,000 |
| 2015/09/15 | 1,886 | 1,914 | 1,854 | 1,877 | +8 | +0.4% | 1,434,000 |
| 2015/09/14 | 1,888 | 1,929 | 1,869 | 1,869 | -17 | -0.9% | 1,526,000 |
| 2015/09/11 | 1,835 | 1,904 | 1,830 | 1,886 | +11 | +0.6% | 3,459,000 |
| 2015/09/10 | 1,866 | 1,900 | 1,848 | 1,875 | -70 | -3.6% | 2,140,000 |
| 2015/09/09 | 1,872 | 1,945 | 1,830 | 1,945 | +132 | +7.3% | 2,437,000 |
| 2015/09/08 | 1,924 | 1,926 | 1,803 | 1,813 | -104 | -5.4% | 1,566,000 |
| 2015/09/07 | 1,905 | 1,939 | 1,873 | 1,917 | +9 | +0.5% | 924,000 |
| 2015/09/04 | 1,978 | 1,981 | 1,888 | 1,908 | -48 | -2.5% | 1,529,000 |
| 2015/09/03 | 2,006 | 2,037 | 1,950 | 1,956 | -33 | -1.7% | 1,713,000 |
| 2015/09/02 | 1,926 | 2,044 | 1,920 | 1,989 | +53 | +2.7% | 1,765,000 |
| 2015/09/01 | 2,014 | 2,033 | 1,934 | 1,936 | -103 | -5.1% | 1,276,000 |
| 2015/08/31 | 2,060 | 2,060 | 2,013 | 2,039 | -26 | -1.3% | 1,221,000 |
| 2015/08/28 | 2,056 | 2,068 | 2,025 | 2,065 | +53 | +2.6% | 1,382,000 |
| 2015/08/27 | 2,005 | 2,039 | 1,993 | 2,012 | +39 | +2% | 1,302,000 |
| 2015/08/26 | 1,909 | 1,986 | 1,909 | 1,973 | +64 | +3.4% | 1,937,000 |
| 2015/08/25 | 1,955 | 2,046 | 1,907 | 1,909 | -97 | -4.8% | 2,590,000 |
| 2015/08/24 | 2,080 | 2,105 | 2,004 | 2,006 | -107 | -5.1% | 1,596,000 |
| 2015/08/21 | 2,117 | 2,138 | 2,098 | 2,113 | -79 | -3.6% | 1,555,000 |
| 2015/08/20 | 2,201 | 2,248 | 2,188 | 2,192 | -20 | -0.9% | 1,048,000 |
| 2015/08/19 | 2,300 | 2,321 | 2,209 | 2,212 | -16 | -0.7% | 1,860,000 |
| 2015/08/18 | 2,250 | 2,281 | 2,217 | 2,228 | +25 | +1.1% | 1,673,000 |
| 2015/08/17 | 2,150 | 2,214 | 2,149 | 2,203 | +78 | +3.7% | 1,138,000 |
| 2015/08/14 | 2,138 | 2,155 | 2,110 | 2,125 | -27 | -1.3% | 1,762,000 |
| 2015/08/13 | 2,050 | 2,160 | 2,026 | 2,152 | +126 | +6.2% | 2,143,000 |
| 2015/08/12 | 2,045 | 2,060 | 1,998 | 2,026 | +13 | +0.6% | 1,377,000 |
| 2015/08/11 | 2,044 | 2,044 | 1,989 | 2,013 | -6 | -0.3% | 1,468,000 |
| 2015/08/10 | 1,997 | 2,031 | 1,991 | 2,019 | +19 | +1% | 1,942,000 |
| 2015/08/07 | 2,032 | 2,032 | 1,977 | 2,000 | -40 | -2% | 1,863,000 |
| 2015/08/06 | 2,090 | 2,090 | 2,033 | 2,040 | -29 | -1.4% | 1,411,000 |
| 2015/08/05 | 2,070 | 2,091 | 2,052 | 2,069 | -3 | -0.1% | 1,469,000 |
| 2015/08/04 | 2,070 | 2,090 | 2,049 | 2,072 | +21 | +1% | 1,949,000 |
| 2015/08/03 | 2,000 | 2,059 | 1,993 | 2,051 | +33 | +1.6% | 1,419,000 |
| 2015/07/31 | 1,993 | 2,035 | 1,965 | 2,018 | +39 | +2% | 1,852,000 |
| 2015/07/30 | 1,960 | 1,989 | 1,949 | 1,979 | +4 | +0.2% | 1,606,000 |
| 2015/07/29 | 1,954 | 1,985 | 1,945 | 1,975 | +9 | +0.5% | 978,000 |
| 2015/07/28 | 1,921 | 1,987 | 1,912 | 1,966 | +33 | +1.7% | 1,575,000 |
| 2015/07/27 | 1,944 | 1,979 | 1,918 | 1,933 | +85 | +4.6% | 2,142,000 |
| 2015/07/24 | 1,847 | 1,862 | 1,840 | 1,848 | -6 | -0.3% | 689,000 |
| 2015/07/23 | 1,843 | 1,865 | 1,816 | 1,854 | +24 | +1.3% | 1,344,000 |
| 2015/07/22 | 1,848 | 1,865 | 1,825 | 1,830 | -17 | -0.9% | 957,000 |
| 2015/07/21 | 1,809 | 1,850 | 1,805 | 1,847 | +38 | +2.1% | 1,126,000 |
| 2015/07/17 | 1,775 | 1,818 | 1,774 | 1,809 | +47 | +2.7% | 1,806,000 |
| 2015/07/16 | 1,750 | 1,770 | 1,739 | 1,762 | +12 | +0.7% | 1,104,000 |
| 2015/07/15 | 1,746 | 1,775 | 1,731 | 1,750 | +4 | +0.2% | 1,430,000 |
2351～
2400
件表示中 / 3698件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 217,400円 | -3.5% | -11.3% | 2.76% | 19.97倍 | 1.34倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 135,300円 | +0.9% | +380.2% | 5.76% | 18.63倍 | 1.60倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 220,700円 | +20.9% | +10.6% | 2.99% | 10.43倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 388,100円 | +1.7% | -2.9% | 4.12% | 25.46倍 | 1.34倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 150,100円 | +0.6% | +43.3% | 5.33% | 10.52倍 | 0.90倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
